Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up

被引:21
|
作者
Hajili, Turkan [1 ]
Ohlmann, Carsten H. [1 ]
Linxweiler, Johannes [1 ]
Niklas, Christina [1 ]
Janssen, Martin [1 ]
Siemer, Stefan [1 ]
Stoeckle, Michael [1 ]
Saar, Matthias [1 ]
机构
[1] Saarland Univ, Dept Urol & Pediat Urol, D-66421 Homburg, Germany
关键词
inductive androgen deprivation; inoperable high-risk prostate cancer; prostate-specific antigen nadir; radical prostatectomy; #pcsm; #ProstateCancer; NEOADJUVANT HORMONAL-THERAPY; HIGH-RISK; PHASE-II; MEN; SURVIVAL; ADENOCARCINOMA;
D O I
10.1111/bju.14393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo determine the outcomes of complete surgical resection of T4 prostate cancer after inductive androgen-deprivation therapy (ADT), as inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet. Patients and MethodsA monocentric RP database was queried for patients initially diagnosed with T4 prostate cancer, considered primarily as inoperable because of a fixed mass defined by rectal examination in combination with high PSA level and/or large foci of biopsy confirmed undifferentiated prostate cancer. Treatment consisted of primary ADT until PSA nadir with consecutive RP. Patients underwent retropubic RP (RRP) or robot-assisted laparoscopic RP (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall survival (OS) and prostate cancer-specific survival (PCSS). ResultsWe retrospectively identified 116 patients treated between 2000 and 2014. At diagnosis, the median (range) PSA level was 37.6 (2.44-284) ng/mL. The preoperative median (range) PSA after inductive ADT was 0.73 (0.01-34) ng/mL. Thereafter, patients underwent RRP or, since 2006, RALP. The median (95% confidence interval) OS was 156 (118.9-193.1) months. The PCSS at 150months was 82%. ConclusionsSurgical therapy of primarily inoperable prostate cancer is feasible and safe after inductive ADT. The OS of this cohort seems comparable with results described for patients with primary operable high-risk prostate cancer.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [31] Long-Term Oncologic Outcome of an Initial Series of Laparoscopic Radical Prostatectomy for Clinically Localized Prostate Cancer After a Median Follow-up of 10 Years
    Mortezavi, Ashkan
    Sulser, Tullio
    Robbiani, Jacopo
    Drescher, Eva
    Disteldorf, Daniel
    Eberli, Daniel
    Poyet, Cedric
    Baumgartner, Martin K.
    Seifert, Hans-Helge
    Hermanns, Thomas
    CLINICAL GENITOURINARY CANCER, 2016, 14 (04) : 290 - 297
  • [32] Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution
    Tomisaki, Ikko
    Ikuta, Hirofumi
    Higashijima, Katsuyoshi
    Onishi, Rei
    Minato, Akinori
    Fujimoto, Naohiro
    CANCER INVESTIGATION, 2019, 37 (10) : 524 - 530
  • [33] WHO DIES FROM PROSTATE CANCER? A COMPREHENSIVE ANALYSIS OF A LARGE SERIES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH LONG-TERM FOLLOW-UP
    Suardi, Nazareno
    Fossati, Nicola
    Gandaglia, Giorgio
    Dell'Oglio, Paolo
    Stabile, Armando
    Zaffuto, Emanuele
    Bravi, Carlo Andrea
    Mazzone, Elio
    Muttin, Fabio
    Tutolo, Manuela
    Deho, Federico
    Damiano, Rocco
    Abdollah, Firas
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2018, 199 (04): : E265 - E266
  • [34] Neurosurgical treatment of pediatric pleomorphic xanthoastrocytomas: long-term follow-up of a single-institution, consecutive series of 12 patients
    Lundar, Tryggve
    Due-Tonnessen, Bernt Johan
    Fric, Radek
    Krossnes, Bard
    Brandal, Petter
    Stensvold, Einar
    Due-Tonnessen, Paulina
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2019, 23 (04) : 512 - 516
  • [35] Long-Term Follow-Up of a Prospective Trial of Neoadjuvant Chemotherapy and Androgen Deprivation Followed by Prostatectomy and Adjuvant Radiation in High-Risk Prostate Cancer
    Kwok, Y.
    Snider, J. W.
    Engelman, A.
    Alexander, R. B.
    Amin, P. P.
    Hussain, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S443 - S444
  • [36] Radical prostatectomy (RP) with extended lymphadenectomy (EPLND) in PT3B-T4 prostate cancer (PCA): Long-term follow-up
    Brausi, M. A.
    De Luca, G.
    Gavioli, M.
    Peracchia, G.
    Verrini, G.
    Viola, M.
    Giliberto, G. L.
    Simonini, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 105 - 105
  • [37] RACIAL DISPARITIES IN ONCOLOGIC OUTCOMES AFTER RADICAL PROSTATECTOMY: LONG-TERM FOLLOW-UP
    Faisal, Farzana
    Sundi, Debasish
    Ross, Ashley
    Humphreys, Elizabeth
    Partin, Alan
    Han, Misop
    Schaeffer, Edward
    JOURNAL OF UROLOGY, 2014, 191 (04): : E928 - E929
  • [38] Racial Disparities in Oncologic Outcomes After Radical Prostatectomy: Long-term Follow-up
    Faisal, Farzana A.
    Sundi, Debasish
    Cooper, John L.
    Humphreys, Elizabeth B.
    Partin, Alan W.
    Han, Misop
    Ross, Ashley E.
    Schaeffer, Edward M.
    UROLOGY, 2014, 84 (06) : 1434 - 1441
  • [39] LONG-TERM ONCOLOGICAL FOLLOW-UP AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY: THE HEILBRONN EXPERIENCE
    Hruza, M.
    Flinspach, B.
    Schulze, M.
    Teber, D.
    Rassweiler, J.
    JOURNAL OF ENDOUROLOGY, 2009, 23 : A174 - A174
  • [40] Long-term follow-up in breast cancer survivors: A single institution survey
    Di Cosimo, S
    Ferretti, G
    Alimonti, A
    Gravante, G
    Silvestris, N
    D'Aprile, M
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2003, 12 (06): : 599 - 600